Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer.

SPRY4 expression patterns followed a similar trend, but the differences between cohorts did not reach statistical significance, confirming our previous statement about the inferior potential of SPRY4 as a marker of MEK/ERK response and baseline activity ( Figure S6 ).

also in 111,027 other papers